Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 25 of 25, showing 3 Applications out of 243 total, starting on record 241, ending on 243

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

241.

ECCT/26/05/01   C1091009 Study site 1193
    Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants   
Principal Investigator(s)
1. Janet Nyawira Oyieko
Site(s) in Kenya
1. KEMRI Butere Clinical Research Centre (Kakamega county)
2. Kenya Medical Research Institute Walter Reed Project (Kericho county)
3. Kenya Medical Research Institute (KEMRI) - Centre for Global Health Research (Kisumu county)
4. Victoria Biomedical Research Institute Kisumu County Referral Hospital (Kisumu county)
 
08-11-2026 View

242.

ECCT/26/06/02   HibiscusJr
    A global phase 3 Randomised, Double-blind and Placebo-controlled Study Evaluating the Efficacy and Safety of etavopivat in children with Sickle Cell Disease.   
Principal Investigator(s)
1. Dr. Sharon Mokeira Ocharo
Site(s) in Kenya
1. Victoria Biomedical Research Institute (Kisumu county)
 
23-10-2026 View

243.

ECCT/26/06/03   C1091009 - Study Site 1254
    Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants   
Principal Investigator(s)
1. Fredrick Kipyego Sawe
Site(s) in Kenya
1. Kenya Medical Research Institute Walter Reed Project (Kericho county)
2. KEMRI Butere Clinical Research Centre (Kakamega county)
3. Kenya Medical Research Institute (KEMRI) - Centre for Global Health Research (Kisumu county)
4. Victoria Biomedical Research Institute Kisumu County Referral Hospital (Kisumu county)
 
08-11-2026 View